Using Biomarker-Based Risk Assessments to Inform Lung Nodule Referral Decisions
This webinar discusses: Current guidelines for lung nodule management The importance of identifying malignant lung nodules Challenges with nodule discovery and referral patterns Stratifying lung nodule patients using biomarker-based risk assessments Moderator: Robbie Lunt Panelist: Susan Garwood, MD This CHEST non-CME webinar is sponsored by Biodesix.
▶︎
Understanding Lung Nodules: Diagnosis, Monitoring & Treatment | 10.18.22 | Lung Cancer Living Room®
▶︎
When and how to intervene on the growing pulmonary nodule
▶︎
Pseudomonas aeruginosa in Patients With Nosocomial Respiratory Infections: A Secondary Analysis o...
▶︎
Acute Myelogenous Leukemia AML: Transplant or Not?
▶︎
Lung Nodules (basics for patients)
▶︎
Reclassifying malignancy risk in indeterminate pulmonary nodules using Nodify Lung™ testing strategy
▶︎
Why Malocclusion in Kids is More Than Just a Dental Issue: Dr. Kevin Boyd’s Perspective
▶︎
Management of Osteoporosis in Patients with CKD || Thomas Nickolas, MD, MS
▶︎
Pulmonology and Managing Multiple Lung Nodules - 06/16/20 - Lung Cancer Living Room™
▶︎
Nonspecific Lung Nodules & Masses | Chest Radiology Essentials
▶︎
My approach to solitary pulmonary nodules
▶︎
Long-Term Side Effects of Brain Tumor Treatment
▶︎
Evaluating the Association Between Patient Priorities and ICU Care Delivery in Adults Receiving M...
▶︎
Approach to Ground Glass Nodules
▶︎
Endobronchial Valve Therapy: A Minimally Invasive Option for Your Patients With Severe COPD
▶︎
Important Role of Beta Amyloid to Alzheimer's Disease
▶︎
Lung Cancer Scans CT, PET and MRIs All you Need to Know
▶︎
Fluoroscopy with Bronchoscopy - BAVLS
▶︎
Sampling and Evaluating Lung Nodules and Masses: Expert Q&A
▶︎